PaulHSaengerMD

PubMed

• Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial
  Lars Sävendahl, Tadej Battelino, Meryl Brod, Michael Højby Rasmussen, Reiko Horikawa, Rasmus Vestergaard Juul, Paul Saenger> ;The Journal of Clinical Endocrinology and Metabolism. 2020 Apr 1
• Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective
  Paulo Ferrez Collett-Solberg, Geoffrey R. Ambler, Philippe Backeljauw, Martin Bidlingmaier, Beverly M. K. Biller, Margaret C. S. Boguszewski, Pik To Cheung, Catherine ...> ;Hormone Research in Paediatrics. 2019 Sep 12
• Growth hormone therapy in children; research and practice - A review
  Paulo Ferrez Collett-Solberg, Alexander A. L. Jorge, Margaret C. S. Boguszewski, Bradley S. Miller, Catherine S. Choong, Pinchas Cohen, Andrew R. Hoffman, Xiaoping Luo...> ;Growth Hormone & Igf Research. 2019 Feb 1
• GHD Diagnostics in Europe and the US: An Audit of National Guidelines and Practice.
  Gerhard Binder, Thomas Reinehr, Lourdes Ibáñez, Susanne Thiele, Agnès Linglart, Joachim Woelfle, Paul Saenger, Markus Bettendorf, Agnieszka Zachurzok, Bettina Gohlke, ...> ;Hormone Research in Paediatrics. 2019 Jan 1
• Three years of growth hormone therapy in children born small for gestational age: results from the ANSWER Program
  Robert Rapaport, Peter A. Lee, Judith L. Ross, Paul Saenger, Vlady Ostrow, Giuseppe Piccoli> ;Endocrine connections. 2018 Aug 23
• Long-Acting Growth Hormone in Idiopathic Short Stature
  Paul Saenger, Luis Zamora-Siliezar> ;Hormone Research in Paediatrics. 2018 Jan 1
• Feeling misguided: a comment on the US guidelines on growth hormone and insulin-like growth factor-I treatment in children and adolescents.
  Paul Saenger, Pinchas Cohen> ;Current Opinion in Pediatrics. 2017 Aug 1
• Ten years of biosimilar recombinant human growth hormone in Europe.
  Paul Saenger> ;Drug Design Development and Therapy. 2017 May 16
• Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
  Jens Sandahl Christiansen, Philippe Backeljauw, Martin Bidlingmaier, Beverly M. K. Biller, Margaret C. S. Boguszewski, Felipe F. Casanueva, Philippe Chanson, Pierre Ch...> ;European Journal of Endocrinology. 2016 Jun 1
• Sodium/Iodide Symporter Mutant V270E Causes Stunted Growth but No Cognitive Deficiency.
  Juan Pablo Nicola, Andrea Reyna-Neyra, Paul Saenger, David Rodriguez-Buritica, José David Gamez Godoy, Radhika Muzumdar, L. Mario Amzel, Nancy Carrasco> ;The Journal of Clinical Endocrinology and Metabolism. 2015 Jul 23
• Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.
  Nazia Rashid, Paul Saenger, Yi-Lin Wu, Heike Woehling, Matthew Frankel, Fima Lifshitz, Michael Muenzberg, Robert Rapaport> ;Biologics in therapy. 2014 Dec 1
• Erratum to: Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.
  Nazia Rashid, Paul Saenger, Yi-Lin Wu, Heike Woehling, Matthew Frankel, Fima Lifshitz, Michael Muenzberg, Robert Rapaport> ;Biologics in therapy. 2014 Dec 1
• Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome - a Chinese experience.
  Di Wu, Chunxiu Gong, Huyong Zheng, Paul Saenger, Yang Zhao, Yi Gu, Bingyan Cao, Wenjing Li, Chang Su> ;Journal of Pediatric Endocrinology and Metabolism. 2014 Nov 1
• 24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.
  Vaman Khadilkar, Klavdia A. Radjuk, Elena Bolshova, Rajesh Khadgawat, Mohamed El Kholy, Meena Desai, Valentina Alexandrovna Peterkova, Verónica Mericq, Jürgen Kratzsch...> ;The Journal of Clinical Endocrinology and Metabolism. 2014 Jan 1
• Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study.
  Robert Rapaport, Paul Saenger, Heinrich Schmidt, Yukihiro Hasegawa, Michel Colle, Sandro Loche, Sandra Marcantonio, Walter Bonfig, Markus Zabransky, Fima Lifshitz> ;Medical Devices : Evidence and Research. 2013 Sep 2
• Trends in the Incidence of Childhood Type 1 Diabetes Mellitus in Beijing Based on Hospitalization Data from 1995 to 2010
  Chunxiu Gong, Xi Meng, Paul Saenger, Dongning Wu, Bingyan Cao, Di Wu, Li-ya Wei> ;Hormone Research in Paediatrics. 2013 Jan 1
• 6 citations
  Genetic factors associated with small for gestational age birth and the use of human growth hormone in treating the disorder
  Paul Saenger, Edward O. Reiter> ;International Journal of Pediatric Endocrinology. 2012 May 15
• Turner syndrome: strategies to improve care outcomes. Foreword.
  Paul Saenger, Carolyn A. Bondy> ;Pediatric endocrinology reviews. 2012 May 1
• Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD)
  Ferenc Péter, Martin Bidlingmaier, Conrad Savoy, Hyi-Jeong Ji, Paul Saenger> ;The Journal of Clinical Endocrinology and Metabolism. 2012 Feb 1
• Long-Term Surveillance of Growth Hormone Therapy
  Ron G. Rosenfeld, Pinchas Cohen, Leslie L. Robison, Barry B. Bercu, Peter E. Clayton, Andrew R. Hoffman, Sally Radovick, Paul Saenger, Martin O. Savage, Jan M. Wit> ;The Journal of Clinical Endocrinology and Metabolism. 2012 Jan 1
• Biosimilar Growth Hormone
  Paul Saenger> ;Indian Journal of Pediatrics. 2012 Jan 1
• Pathophysiology, assessment and management of the child with growth hormone resistance.
  Martin O. Savage, Laurie E. Cohen, Cohen Aj, Pinchas Cohen, Paul Saenger> ;Pediatric endocrinology reviews. 2010 Jun 1
• Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omn...
  Uwe Fuhr, Daniel Tuculanu, Alexander Berghout, Sigrid Balser, Arnd Schwebig, Paul Saenger> ;European Journal of Endocrinology. 2010 Jun 1
• Current Status of Biosimilar Growth Hormone
  Paul Saenger> ;International Journal of Pediatric Endocrinology. 2009 Aug 23
• Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency
  Ferenc Péter, Conrad Savoy, Hyi-Jeong Ji, Mihaly Juhasz, Martin Bidlingmaier, Paul Saenger> ;European Journal of Endocrinology. 2009 Mar 1
• Join now to see all

Other

• Ten Years of Biosimilar Recombinant Human Growth Hormone in Europe 
  Paul Saenger, MD, Drug Design, Development and Therapy
  https://www.doximity.com/articles/d8e8a18f-f6c5-4ce6-83d4-db55f13b40d9
  UpToDate, Wolters Kluwer Health - 2013-03-05
• Ten Years of Biosimilar Recombinant Human Growth Hormone in Europe 
  Paul Saenger, MD, Drug Design, Development and Therapy
  https://www.doximity.com/articles/d8e8a18f-f6c5-4ce6-83d4-db55f13b40d9
  UpToDate, Wolters Kluwer Health - 2013-04-01
• Ten Years of Biosimilar Recombinant Human Growth Hormone in Europe 
  Paul Saenger, MD, Drug Design, Development and Therapy
  https://www.doximity.com/articles/d8e8a18f-f6c5-4ce6-83d4-db55f13b40d9
  UpToDate, Wolters Kluwer Health - 2012-11-16
• Ten Years of Biosimilar Recombinant Human Growth Hormone in Europe 
  Paul Saenger, MD, Drug Design, Development and Therapy
  https://www.doximity.com/articles/d8e8a18f-f6c5-4ce6-83d4-db55f13b40d9
  UpToDate, Wolters Kluwer Health - 2012-10-24
• Join now to see all